The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sterility Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Manufacturing Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Perspective (2018-2029)
2.2 Cell and Gene Therapy Manufacturing Quality Control Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Region (2018-2023)
2.2.3 Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Region (2024-2029)
2.3 Cell and Gene Therapy Manufacturing Quality Control Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Quality Control Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Quality Control Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Quality Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Quality Control Players by Revenue (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Quality Control Revenue
3.4 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2022
3.5 Cell and Gene Therapy Manufacturing Quality Control Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing Quality Control Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing Quality Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Type (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Type (2024-2029)
5 Cell and Gene Therapy Manufacturing Quality Control Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Quality Control Historic Market Size by Application (2018-2023)
5.2 Global Cell and Gene Therapy Manufacturing Quality Control Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
6.2 North America Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
6.4 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
7.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
9.2 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
9.4 Latin America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad Laboratories,Inc.
11.1.1 Bio-Rad Laboratories,Inc. Company Detail
11.1.2 Bio-Rad Laboratories,Inc. Business Overview
11.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.1.4 Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.1.5 Bio-Rad Laboratories,Inc. Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Introduction
11.2.4 QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.2.5 QIAGEN Recent Development
11.3 Charles River Laboratories International, Inc.
11.3.1 Charles River Laboratories International, Inc. Company Detail
11.3.2 Charles River Laboratories International, Inc. Business Overview
11.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.3.4 Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.3.5 Charles River Laboratories International, Inc. Recent Development
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Detail
11.4.2 Lonza Group AG Business Overview
11.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Introduction
11.4.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.4.5 Lonza Group AG Recent Development
11.5 Bio-Techne Corporation
11.5.1 Bio-Techne Corporation Company Detail
11.5.2 Bio-Techne Corporation Business Overview
11.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Introduction
11.5.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.5.5 Bio-Techne Corporation Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Introduction
11.6.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Detail
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Ltd Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Detail
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 Intertek Group Plc
11.9.1 Intertek Group Plc Company Detail
11.9.2 Intertek Group Plc Business Overview
11.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Introduction
11.9.4 Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.9.5 Intertek Group Plc Recent Development
11.10 Eurofins Scientific S.E.
11.10.1 Eurofins Scientific S.E. Company Detail
11.10.2 Eurofins Scientific S.E. Business Overview
11.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Introduction
11.10.4 Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
11.10.5 Eurofins Scientific S.E. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details